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1804-31 A Double Blind Randomized Trial of a 24 Hour
Infusion of Magnesium Sulphate in Unstable Angina
Simon Redwood, Edward Leatham, Jian Huang, Jose Vazquez, Yaver Bashir,
Juan-Carlos Kaski, John Camm. St George's Hospital, London, England
Magnesium IMg2+) has been shown to reduce coronary spasm, have fa-
vorable hemodymamic effects, inhibit platelet function, reduce arrhythmias,
modulate autonomic function, reduce catecholamine secretion and to be
protective during experimental acute myocardial ischemia.
Sixty-two consecutive patients with unstable angina (rest pain < 24 hours,
STrr changes and normal admission CK) were randomized in a double-blind
fashion to Mg2+ (8 mmol bolus, then 3.0 mmollh for 24 hours) or placebo
within 12 hours of admission. All patients received aspirin, f3 blockade, iv
nitrates and heparin, provided no contraindications existed. Four consecu-
tive 12 hour urine collections were started at study entry for estimation of
catecholamines (n = 31) or f3 thromboglobulin (n = 31).
84% underwent predischarge angiography. Baseline characteristics and
extent of coronary disease were similar in both groups. Serum Mg2+ rose
from 0.91 ± 0.02 to 1.71 ± 0.05 mmolll (mean ± SEM) in the Mg2+ group.
CKMB release was less in the Mg2+ group at 6 and 24 hours (28.3 ± 7.4
vs 6.6 ± 1.2 ng/ml at 6 hrs, p< 0.05). Regression of T wave changes on the
24 hour ECGs (compared with admission ECGs) occurred more frequently
in the Mg2+ group (11 patients vs 0 patients, p < 0.005). On 48 hour Holter
monitoring, a similar proportion had transient myocardial ischemia (TMI) in
the two groups (16 (52%) in the Mg2+ group vs 15 (48%) in the placebo
group), however there were fewer episodes of TMI in the Mg2+ group (57
vs 118, p < 0.0001) with a median total duration of 31.45 vs 102.73 mins re-
spectively (p = ns). Frequency of ventricular ectopy and non-sustained ven-
tricular tachycardia were similar in both groups. Heart rate variability was
significantly lower in the placebo group in the 24 hours following, but not
during, the infusion. Epinephrine excretion was lower in the Mg2+ group in
the first 12 hour sample (1.05 ± 0.20 vs 1.61 ± 0.41 ng/mmol creat., p <
0.051, with no significant difference in norepinephrine excretion. Urinary f3
thromboglobulin was similar in both groups in all collections.
Thus Mg2+ appears to reduce CKMB release, ECG progression and cate-
cholamines in the acute phase of unstable angina with no effect on f3 throm-
boglobulin excretion suggesting that its effect may be mediated via auto-
nomic modulation but not platelet function. A larger scale trial investigating
the effect of Mg2+ on mortality is warranted.
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A Randomized, Double-blind Trial of Streptokinase
Versus Placebo for the Management of Unstable
Angina and Non·Q·wave Myocardial Infarction In
Patients with Previous Coronary Artery Bypass
Surgery
Faryala Shabani, Pierre Theroux, Pierre de Guise, Bernard Thibault Montreal Heart
Institute, Montreal, Quebec, Canada
This trial investigated the potential usefulness of thrombolysis in patients
with previous coronary artery bypass surgery admired for unstable angina
and non-a-wave myocardial infarction, the rationale being more frequent
non-a-wave infarction in these patients and a high-fibrin content of older
grafts. A total of 125 consecutive patients with symptoms evolving for less
than 24 hr were randomized to intravenous streptokinase 1.5 million Units
in 45 min, or to placebo. All patients received concomitant intravenous hep-
arin, oral aspirin and standard anti-ischemic therapy. Mean age (62 ± 9 yrs).
sex (78% male). time of previous surgery (8 ± 0.5 yrsl, presence of a previ-
ous myocardial infarction (63%). prior medication including aspirin in 66%,
an abnormal ECG at admission (79%) and time to treatment after the last
ischemic episode (10 ± 9 hr) were similar in the 2 study groups.
Fatal and non-fatal myocardial infarctions in hospital occurred in 7 strep-
tokinase (11.1 %) and 3 placebo (4.8%) patients (relative risk 2.3, 95% confi-
dence limits 0.62-8.48, p = 0.19) and at 1 month in an additional 2 patients in
each group. Refractory angina in hospital was observed in 12 (19.1 %) strep-
tokinase patients and 13 (20.9%) placebo patients. A revascularization proce-
dure because of recurrent symptoms was required at 1 month in respectively
22 (34.9%) and 16 (25.8%) patients.
Conclusion: The early cardiac event rate in unstable angina associated with
previous bypass surgery is high. The nonsignificant excess in the risk of my-
ocardial infarction with streptokinase in this population most likely to benefit,
is similar to the excess reported in other populations of patients with unsta-
ble angina and non-a-wave myocardial infarction and supports the lack of
benefit of thrombolysis in unstable angina.
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Theophylline Reverses Myocardial Infarction-Related
Brady and Tachy Arrhythmias: Role of Adenosine
Barry D. Bertole!, James A. Hill, Luiz Belardinelli. University of Florida, GainesvJ1le, FL
Brady and tachyarrhythmias often complicate the early management of
acute myocardial infarction (Mil. Endogenously released adenosine (ADO)
from ischemic cardiac cells has been proposed as a potential mediator of
these arrhythmias. In order to test this hypothesis, theophylline (THEa). a
competitive ADO receptor antagonist, was administered to nine patients
who developed sustained or hemodynamically significant brady or tach-
yarrhythmias immediately following an acute inferior MI.
Methods: Once such an arrhythmia was detected, continuous ECG moni-
toring was begun. THEa was then administered Lv. at a rate of 100 mglmin
until the arrhythmia resolved or a maximum of 250 mg THEO was infused.
Patients were then monitored for 24 hours for recurrent arrhythmias.
Results: Bradyarrhythmias were detected in 5 patients (3 with 3° AV block,
2 with 2° AV block). Tachyarrhythmias were detected in four patients (2 with
atrial fibrillation, 2 with accelerated idioventricular rhythm). All patients con-
verted to normal sinus rhythm within five minutes of the administration of
THEa (178 ± 57 mg). No recurrent arrhythmia occurred in the follow-up pe-
riod.
Conclusions: Many of the brady and tachyarrhythmias which occur early
after inferior MI are ADO-mediated. ADO receptor antagonism appears ef-
fective in converting these arrhythmias to normal sinus rhythm and may be
considered as primary therapy.
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/805-21 Faster but not more Complete Thrombolysis with
Tissue Plasminogen Activator than with
Streptokinase In Massive Pulmonary Embolism
Nicolas Meneveau, Fran~ois Schiele, Fran~ois Barthes, Alain Vuillemeno!,
Thierry Angueno!, Benoit Valette, Gilles Grollier, Yvette Bernard,
Jean-Pierre Bassand. Hopital Universitaire St.Jacques, Besan,on, France; Hopital
Universitaire Caen, France
Mean pulmonary artery pressure (MPA), cardiac output (CO), and right ven-
tricular ejection fraction (RVEF) were serially assessed with use of a 5-way,
rapid response rate, Swan-Ganz catheter in 45 Pts submitted to throm-
bolytic therapy (TI) for massive pulmonary embolism (PE) defined as Miller
score < 17/34, and mean pulmonary artery pressure >20 mmHg. Total pul-
monary resistance (TPR) was determined from MPA and CO and expressed
in dynes/sec/cm-5. Pulmonary angiography was performed before and 24
h after TI. Streptokinase (STK) was used in 22 Pts, and tissue plasminogen
activator (t-PA) in 23.
TO T 1h T2h T 12 h
TPR-STK 701 ± 261 591 ± 203 583±211 380 ± 155
TPR+PA 735 ± 390 508 ± 330 405 ± 210* 338 ± 142
RVEF-STK 0.18 ± 0.02 0.20 ± 0.07 020 ± 0.09 026 ± 0.10
RVEF+PA 0.18 ± 0.08 024 ± 0.09 0.27 ± 0.09* 029 ± 0.09
*p < 0.05 between STK and t-PA
A significant decrease in TPR inversely correlated to a significant increase
in RVEF occurred in both treatment groups, but significantly more rapidly in
the t-PA group than in the STK group. The difference was significant 2 hand
4 h after onset of TI, but had vanished at 12 h. Miller score, similar in both
groups before TI, was identical in both groups at 24 h.
Conclusion: t-PA induced a significantly faster hemodynamic improvement
than STK in massive PE, but with a catch-up phenomenon apparent 12 h after
onset of therapy.
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1805-31 Diagnostic Value of Transesophageal
Echocardiography During Cardiopulmonary
Resuscitation
Poll A. van der Wouw, Rudolph W. Koster, Ben J. Delemarre, Rien de Vas, Dick van
Groeningen Academic Medical Center, Amsterdam, the Netherlands
Transesophageal echocardiography (TEE) permits the visualisation of the
heart and great vessels without disturbing resuscitation attempts. Early in-
formation about the cause of the circulatory arrest can help in reestablishing
